EdelGive and Hurun India recognizes Kiran Mazumdar-Shaw as the Second most generous women philanthropist in India

  • Posted by: Biocon Biologics

Biocon Biologics Announces Divestment of Two Non-Core Branded Formulations – India Business Units

  • Posted by: Biocon Biologics

Biocon Ranked No. 8 Among Science Magazine’s Best Employers in Global Biotech and Pharma Sector

  • Posted by: Biocon Biologics

Kedar Upadhye Appointed as New CFO of Biocon Biologics Current CFO MB Chinappa to take on a Strategic Finance role at Biocon Group

  • Posted by: Biocon Biologics

Update on U.S. FDA Inspection at Biocon Biologics’ Manufacturing Facility in Johor, Malaysia

  • Posted by: Biocon Biologics

Biocon Biologics Receives Complete Response Letter from US FDA for Biosimilar Insulin Aspart

  • Posted by: Biocon Biologics

Biocon Biologics Receives European Commission Approval for YESAFILI®, Biosimilar Aflibercept

  • Posted by: Biocon Biologics

Biocon Board Appoints Peter Bains as Group CEO

  • Posted by: Biocon Biologics

Biocon Biologics Continues to Expand Global Footprint, Completes Integration of Viatris Biosimilars’ Business In North America, Ahead of Schedule

  • Posted by: Biocon Biologics

Biocon Q1FY24 Revenue at Rs 3,516 Cr, Up 59%; Biosimilars Up 106%; Research Services Up 25%

  • Posted by: Biocon Biologics
Share
buy twitter followers